CRP and Stroke: Notably, the JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) specifically demonstrated that at-risk individuals with elevated high-sensitivity CRP (hs-CRP) but normal cholesterol can significantly reduce their risk of MI and stroke by taking statins [17].